Private Equity

Stanley Capital

Investment Details

Investor Type
Private Equity

Asset Class Focus
Private Equity

Stage Focus
Growth, Buyout

Geographical Focus
United States, United Kingdom, Germany, France, Italy, Denmark, Switzerland, Spain, Luxembourg, Ireland, Austria, Netherlands, Portugal, Sweden, Belgium, Greece, Norway, Finland, Poland, Czech Republic

Industries Focus

  • Technology
  • Healthcare
  • Resource Efficiency

Investment Size:
250,000,000 to 2,500,000,000 USD

Investor Details Founded: 2019

Stanley Capital is an independent mid-market private equity firm that partners with management teams to create value through mergers and acquisitions, operational change, and technology enablement. Founded in 2019, the firm focuses on growing sustainable businesses in the Healthcare, Technology, and Resource Efficiency sectors across Europe and the United States. Stanley Capital targets companies with enterprise values ranging from $250 million to $2.5 billion.

The firm's investment strategy involves a research and technology-driven approach to identify opportunities in the growing sustainable investment sectors of Resource Efficiency, Healthcare, and Technology. Stanley Capital partners with management teams in both majority and minority transactions to transform companies through growth via technology change, operational change, and market consolidation. The firm employs a system-wide approach, leveraging its specialist skillset in sector research, mergers and acquisitions, and digital transformation to find and unlock sustainable value for its portfolio.

Since its inception, Stanley Capital has been actively involved in various investments and strategic partnerships. Notably, in January 2022, the firm formed a strategic partnership with Grafine Partners to invest in growing sustainable businesses. Additionally, Stanley Capital listed its first Special Purpose Acquisition Vehicle, Healthcare AI Acquisition Corp., on the NASDAQ under the ticker HAIA in December 2021. The firm continues to expand its portfolio and strengthen its team to support its growth and transformation initiatives.

Requirements
  • Sustainable business models
  • Growth potential
  • Alignment with firm's sectors of interest
Contact

[Official Website Hidden]

[HQ Location Hidden]

[Email Hidden]

Portfolio Companies
  • SePRO Corporation
  • Roboyo
  • Laboratoire XO
  • Qinecsa
  • DSS
  • Applied Artificial Intelligence Corporation
  • Noden Pharma
  • LXO
  • Nimotop®
  • My Meds and Me
  • Grafine Partners
  • HAIA
Claim this Investor

Are you an official representative of Stanley Capital?

Claim this investor to update information, manage your profile, and get a verified seal.

Claim